Pharmacogenomics of Scopoletin in Tumor Cells
Drug resistance and the severe side effects of chemotherapy necessitate the development of novel anticancer drugs. Natural products are a valuable source for drug development. Scopoletin is a coumarin compound, which can be found in several Artemisia species and other plant genera. Microarray-based...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2016-04-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1420-3049/21/4/496 |
| _version_ | 1811267807346688000 |
|---|---|
| author | Ean-Jeong Seo Mohamed Saeed Betty Yuen Kwan Law An Guo Wu Onat Kadioglu Henry Johannes Greten Thomas Efferth |
| author_facet | Ean-Jeong Seo Mohamed Saeed Betty Yuen Kwan Law An Guo Wu Onat Kadioglu Henry Johannes Greten Thomas Efferth |
| author_sort | Ean-Jeong Seo |
| collection | DOAJ |
| description | Drug resistance and the severe side effects of chemotherapy necessitate the development of novel anticancer drugs. Natural products are a valuable source for drug development. Scopoletin is a coumarin compound, which can be found in several Artemisia species and other plant genera. Microarray-based RNA expression profiling of the NCI cell line panel showed that cellular response of scopoletin did not correlate to the expression of ATP-binding cassette (ABC) transporters as classical drug resistance mechanisms (ABCB1, ABCB5, ABCC1, ABCG2). This was also true for the expression of the oncogene EGFR and the mutational status of the tumor suppressor gene, TP53. However, mutations in the RAS oncogenes and the slow proliferative activity in terms of cell doubling times significantly correlated with scopoletin resistance. COMPARE and hierarchical cluster analyses of transcriptome-wide mRNA expression resulted in a set of 40 genes, which all harbored binding motifs in their promoter sequences for the transcription factor, NF-κB, which is known to be associated with drug resistance. RAS mutations, slow proliferative activity, and NF-κB may hamper its effectiveness. By in silico molecular docking studies, we found that scopoletin bound to NF-κB and its regulator IκB. Scopoletin activated NF-κB in a SEAP-driven NF-κB reporter cell line, indicating that NF-κB might be a resistance factor for scopoletin. In conclusion, scopoletin might serve as lead compound for drug development because of its favorable activity against tumor cells with ABC-transporter expression, although NF-κB activation may be considered as resistance factor for this compound. Further investigations are warranted to explore the full therapeutic potential of this natural product. |
| first_indexed | 2024-04-12T21:09:27Z |
| format | Article |
| id | doaj.art-5cf86ba5504e4a949a1c66484364a4f5 |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-04-12T21:09:27Z |
| publishDate | 2016-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-5cf86ba5504e4a949a1c66484364a4f52022-12-22T03:16:37ZengMDPI AGMolecules1420-30492016-04-0121449610.3390/molecules21040496molecules21040496Pharmacogenomics of Scopoletin in Tumor CellsEan-Jeong Seo0Mohamed Saeed1Betty Yuen Kwan Law2An Guo Wu3Onat Kadioglu4Henry Johannes Greten5Thomas Efferth6Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Staudinger Weg 5, 55128 Mainz, GermanyDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Staudinger Weg 5, 55128 Mainz, GermanyState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, ChinaDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Staudinger Weg 5, 55128 Mainz, GermanyAbel Salazar Biomedical Sciences Institute, University of Porto, Porto 4099-002, PortugalDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Staudinger Weg 5, 55128 Mainz, GermanyDrug resistance and the severe side effects of chemotherapy necessitate the development of novel anticancer drugs. Natural products are a valuable source for drug development. Scopoletin is a coumarin compound, which can be found in several Artemisia species and other plant genera. Microarray-based RNA expression profiling of the NCI cell line panel showed that cellular response of scopoletin did not correlate to the expression of ATP-binding cassette (ABC) transporters as classical drug resistance mechanisms (ABCB1, ABCB5, ABCC1, ABCG2). This was also true for the expression of the oncogene EGFR and the mutational status of the tumor suppressor gene, TP53. However, mutations in the RAS oncogenes and the slow proliferative activity in terms of cell doubling times significantly correlated with scopoletin resistance. COMPARE and hierarchical cluster analyses of transcriptome-wide mRNA expression resulted in a set of 40 genes, which all harbored binding motifs in their promoter sequences for the transcription factor, NF-κB, which is known to be associated with drug resistance. RAS mutations, slow proliferative activity, and NF-κB may hamper its effectiveness. By in silico molecular docking studies, we found that scopoletin bound to NF-κB and its regulator IκB. Scopoletin activated NF-κB in a SEAP-driven NF-κB reporter cell line, indicating that NF-κB might be a resistance factor for scopoletin. In conclusion, scopoletin might serve as lead compound for drug development because of its favorable activity against tumor cells with ABC-transporter expression, although NF-κB activation may be considered as resistance factor for this compound. Further investigations are warranted to explore the full therapeutic potential of this natural product.http://www.mdpi.com/1420-3049/21/4/496ABC-transportercluster analysiscoumarinherbal medicinemicroarraysmultidrug resistancephytotherapy |
| spellingShingle | Ean-Jeong Seo Mohamed Saeed Betty Yuen Kwan Law An Guo Wu Onat Kadioglu Henry Johannes Greten Thomas Efferth Pharmacogenomics of Scopoletin in Tumor Cells Molecules ABC-transporter cluster analysis coumarin herbal medicine microarrays multidrug resistance phytotherapy |
| title | Pharmacogenomics of Scopoletin in Tumor Cells |
| title_full | Pharmacogenomics of Scopoletin in Tumor Cells |
| title_fullStr | Pharmacogenomics of Scopoletin in Tumor Cells |
| title_full_unstemmed | Pharmacogenomics of Scopoletin in Tumor Cells |
| title_short | Pharmacogenomics of Scopoletin in Tumor Cells |
| title_sort | pharmacogenomics of scopoletin in tumor cells |
| topic | ABC-transporter cluster analysis coumarin herbal medicine microarrays multidrug resistance phytotherapy |
| url | http://www.mdpi.com/1420-3049/21/4/496 |
| work_keys_str_mv | AT eanjeongseo pharmacogenomicsofscopoletinintumorcells AT mohamedsaeed pharmacogenomicsofscopoletinintumorcells AT bettyyuenkwanlaw pharmacogenomicsofscopoletinintumorcells AT anguowu pharmacogenomicsofscopoletinintumorcells AT onatkadioglu pharmacogenomicsofscopoletinintumorcells AT henryjohannesgreten pharmacogenomicsofscopoletinintumorcells AT thomasefferth pharmacogenomicsofscopoletinintumorcells |